81: Neurodevelopmental Outcomes of Extremely Preterm Infants Treated with Bevacizumab for Severe Retinopathy of Prematurity

Authors :: Marie-Noëlle Simard
Francine Lefebvre
Thuy Mai Luu
E Kelly
Julie Morin
V Shah
Prachi E. Shah
Rosanne Superstein
Source :: Paediatrics & Child Health. 20:e63-e63
Publication Year :: 2015
Publisher :: Oxford University Press (OUP), 2015.

Subjects :: Pediatrics
medicine.medical_specialty
Bevacizumab
business.industry
Objective (goal)
Birth weight
Extremely preterm
Retinopathy of prematurity
medicine.disease
Bayley Scales of Infant Development
Laser therapy
Pediatrics, Perinatology and Child Health
Medicine
business
medicine.drug

Tools